Join
Live feed
·
NEWSReleasevia Quantisnow
Zogenix Inc. logo

Zogenix Supports New No-Cost Genetic Testing Program With United Mitochondrial Disease Foundation To 'Improve Diagnosis of Mitochondrial Diseases'

ByQuantisnow·Wall Street's wire, on your screen.
ZGNX· Zogenix Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZGNX (Zogenix Inc.) and more on Quantisnow.